|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/485 | |
| A61K 9/20 | |||
| A61P 25/04 |
| (11) | Number of the document | 1404331 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02744835.6 |
| Date of filing the European patent application | 2002-07-03 | |
| (97) | Date of publication of the European application | 2004-04-07 |
| (45) | Date of publication and mention of the grant of the patent | 2007-10-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2002/021403 |
| Date | 2002-07-03 |
| (87) | Number | WO 2003/004033 |
| Date | 2003-01-16 |
| (30) | Number | Date | Country code |
| 303357 P | 2001-07-06 | US | |
| 329352 P | 2001-10-15 | US | |
| 329426 P | 2001-10-15 | US |
| (72) |
BAICHWAL, Anand, R., US
KAO, Huai-Hung, US
MCCALL, Troy, W., US
|
| (73) |
Penwest Pharmaceuticals Co.,
2981 Route 22, Patterson, NY 12563-9970,
US
|
| (54) | SUSTAINED RELEASE FORMULATIONS OF OXYMORPHONE |
| SUSTAINED RELEASE FORMULATIONS OF OXYMORPHONE |